Blumer JL - Search Results

1

Single-dose pharmacokinetics of aztreonam in children with cystic fibrosis.

Reed MD, Aronoff SC, Stern RC, Yamashita TS, Myers CM, Friedhoff LT, Blumer JL. Reed MD, et al. Among authors: blumer jl. Pediatr Pulmonol. 1986 Sep-Oct;2(5):282-6. doi: 10.1002/ppul.1950020506. Pediatr Pulmonol. 1986. PMID: 3774385

2

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis.

Reed MD, Stern RC, Bertino JS Jr, Myers CM, Yamashita TS, Blumer JL. Reed MD, et al. Among authors: blumer jl. J Pediatr. 1984 Feb;104(2):303-7. doi: 10.1016/s0022-3476(84)81019-7. J Pediatr. 1984. PMID: 6607329

3

Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.

Reed MD, Rekate HL, Aronoff SC, Myers CM, Blumer JL. Reed MD, et al. Among authors: blumer jl. Clin Pharm. 1983 Nov-Dec;2(6):558-63. Clin Pharm. 1983. PMID: 6317277

4

Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents.

Abdel-Rahman SM, Kearns GL, Topelberg S, Jacobs RF, Mistry GC, Majumdar A, Xu Y, Wagner JA, Kitchen CJ, Groff M, Herman G, Blumer JL. Abdel-Rahman SM, et al. Among authors: blumer jl. Pediatr Infect Dis J. 2010 Dec;29(12):1072-6. doi: 10.1097/INF.0b013e3181e82608. Pediatr Infect Dis J. 2010. PMID: 20571461 Free PMC article.

5

The pharmacokinetics of colistin in patients with cystic fibrosis.

Reed MD, Stern RC, O'Riordan MA, Blumer JL. Reed MD, et al. Among authors: blumer jl. J Clin Pharmacol. 2001 Jun;41(6):645-54. doi: 10.1177/00912700122010537. J Clin Pharmacol. 2001. PMID: 11402633

6

Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.

Reed MD, Stern RC, Yamashita TS, Ackers I, Myers CM, Blumer JL. Reed MD, et al. Among authors: blumer jl. Antimicrob Agents Chemother. 1984 May;25(5):579-81. doi: 10.1128/aac.25.5.579. Antimicrob Agents Chemother. 1984. PMID: 6732226 Free PMC article.

7

Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response.

Kercsmar CM, Stern RC, Reed MD, Myers CM, Murdell D, Blumer JL. Kercsmar CM, et al. Among authors: blumer jl. J Antimicrob Chemother. 1983 Jul;12 Suppl A:289-95. doi: 10.1093/jac/12.suppl_a.289. J Antimicrob Chemother. 1983. PMID: 6352634

8

Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis.

Krilov LR, Blumer JL, Stern RC, Hartstein AI, Iglewski BN, Goldmann DA. Krilov LR, et al. Among authors: blumer jl. Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S482-9. doi: 10.1093/clinids/7.supplement_3.s482. Rev Infect Dis. 1985. PMID: 3901211 Clinical Trial.

9

Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.

Blumer JL, Stern RC, Klinger JD, Yamashita TS, Meyers CM, Blum A, Reed MD. Blumer JL, et al. Am J Med. 1985 Aug 9;79(2A):37-46. doi: 10.1016/0002-9343(85)90259-1. Am J Med. 1985. PMID: 3895917

10

Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.

Reed MD, Stern RC, O'Brien CA, Yamashita TS, Myers CM, Blumer JL. Reed MD, et al. Among authors: blumer jl. Antimicrob Agents Chemother. 1985 Apr;27(4):583-8. doi: 10.1128/aac.27.4.583. Antimicrob Agents Chemother. 1985. PMID: 3859245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results